Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Foam or liquid? new study tests best way to treat spider veins

NCT ID NCT07162844

First seen Nov 01, 2025 · Last updated Jun 23, 2026 · Updated 24 times

Summary

This trial compares liquid and foam sclerotherapy for treating spider veins and reticular veins, with or without a herbal gel after the procedure. About 508 adults with mild venous disease will receive one of four treatments. The goal is to see which approach improves appearance best and causes fewer side effects like bruising or pigmentation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for TELANGECTASIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Faculty of medicine kfs university

    Kafr ash Shaykh, Kafr el-Sheikh Governorate, 33511, Egypt

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

polidocanol (a sclerosing agent)

What this could lead to

If successful, this could show which form of sclerotherapy works best for spider veins and whether adding herbal gel improves results or reduces side effects.

What could go wrong

This is a single-center trial with no blinding, so results may be biased. The herbal gel is not a standard treatment, and its effects are uncertain.

Conditions

The condition(s) this trial relates to.

livedo reticularis telangiectasis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.